Zacks Investment Research Issues Research Update on Access Pharmaceuticals, Inc.
Access Pharmaceuticals, Inc.'s Partner Launches Multi-Channel Product Marketing Program For MuGard
Access Pharmaceuticals Signs Exclusive Specialty Distribution Agreement With BioScrip